Dr. Kaveh Kahen, Senior Director and General Manager of Mass Spectrometry at PerkinElmer, highlights technical challenges in cannabis testing and how they can help labs in this growing industry.
Arvind Kothandaraman, PerkinElmer’s General Manager, Specialty Diagnostics, shares his thoughts on how COVID-19 will continue to transform modern laboratories in 2021 and beyond.
EUROIMMUN’s Antigen ELISA is a laboratory test, able to be applied in semi-quantitative automatable detection of the SARS-CoV-2 nucleocapsid protein on a large scale.
Carterra, with the expertise in label-free high throughput antibody screening and characterization, announced that they have closed on a round of equity financing led by PerkinElmer.
The CE-marked EURORealTime SARS-CoV-2/Influenza A/B is capable of differentiating the genetic material from SARS-CoV-2, influenza virus type A and influenza virus type B.
The Management Top 250 ranking measures corporate effectiveness by examining performance in five areas: customer satisfaction, employee engagement and development, innovation, social responsibility and financial strength.
PerkinElmer has announced the MaxSignal™ HTS Total Aflatoxins and DON ELISA Kits featuring automated and easy-to-use mycotoxin testing workflows. This can process up to 192 samples in less than 90 minutes.
This article takes a look back on the evolution of PerkinElmer’s ICP-MS innovations for environmental testing over the past three decades up through the new NexION 5000.
As the second Lighthouse Lab brought online by PerkinElmer on behalf of the DHSC, the Charnwood Lighthouse Lab will increase its daily testing capacity to 50,000 by early 2021.
Our Head of Food, Greg Sears, talks with New Food about trends in food testing and quality, as well as how PerkinElmer’s solutions can help customers meet food and cannabis regulations.
PerkinElmer has launched the newest ChemOffice+ Cloud application for chemistry communication workflows. This offering shifts the inefficient procedures to a new, intuitive cross-document search.
PerkinElmer hosted an exhibit at the Chinese International Import Expo (CIIE) where industry leaders could get an in-person look at our technologies including explorer™ workstations for SARS-CoV-2 testing.
EUROIMMUN, a PerkinElmer company, has launched the new ELISA assay to quantify IgG antibodies against the SARS-CoV-2 S1 antigen.
PerkinElmer has agreed to acquire Horizon Discovery, a company based in the UK that offers gene editing and gene modulation tools, to expand the portfolio of automated Life Sciences and Applied Genomics.
Carola Schmidt, Global Director of Automated Solutions at PerkinElmer, shared her insight about biobanking and how to ensure the integrity and security to standardize the procedure and implement best practices.
Innovative private-public partnership with PerkinElmer will soon allow California to process an additional 150,000 COVID-19 tests a day.
PerkinElmer’s COVID-19 Nucleic Acid Detection Kit is certified for sample pooling to allow a greater number of individuals to be tested without increasing resources.
With the flu season approaching, PerkinElmer has received CE-IVD for the PKamp Respiratory SARS-CoV-2 RT-PCR Panel that simultaneously tests COVID-19, the flu and RSV with only one sample.
PerkinElmer JANUS G3 automated liquid handlers and chemagic 360 closed loop extraction unit have helped Synergy Diagnostic Laboratory in delivering COVID-19 tests to increase the capacity to more than 1,000 tests per shift.
James Coffin, President and Chief Operating Officer, Sema4, talks about how PerkinElmer is providing best-in-class, highly accurate PCR tests (7:40 mark).
The National Center for Advancing Translational Sciences (NCATS) at National Institutes of Health (NIH) is using PerkinElmer’s AlphaLISA no-wash immunoassay to conduct drug compound screening as part of the search for drug repurposing candidates for COVID-19.
PerkinElmer supports BioMarin, a biopharmaceutical firm, for their sponsored testing program in Mexico to identify Batten disease and mucopolysaccharidosis (MPS) disorders.
PerkinElmer launched the industry’s first fully-automated liquid handling sample preparation and LC/MS/MS analysis workflow to detect pesticide residue in cannabis and hemp flower samples.
PerkinElmer helps ramp up testing at “Lighthouse Lab” for Public Health Wales. This aims to expand the capacity to 20,000 tests per day by the end of October.
Adding to the entire newborn screening solutions, PerkinElmer EONIS newborn screening assay simultaneously tests for SMA, SCID and ELA.
Gary Grecsek, Vice President/General Manager of Global OneSource Enterprise Laboratory Services and Tony Pezzolo, Product Manager of Validation, discuss how labs can stay in the know and ahead of the curve on compliance and data integrity challenges with the help of an external, expert compliance team.
Listeria carries a 20 – 30% mortality rate for those in high-risk categories so vigilant testing is important. The PerkinElmer Solus Listeria monocytogenes ELISA Assay tests both food and environmental samples and has been certified by the AOAC.
The FDA released comparative performance data for 58 COVID-19 test manufacturers. PerkinElmer’s detection kit that uses nasopharyngeal swabs in viral transport media topped the list.
Madhuri Hegde, Vice President and Chief Scientific Officer at PerkinElmer Genomics, shared how recent advancements in genomic sequencing technologies are enabling simultaneous rapid analysis for large amounts of genetic information, making it easier and faster to apply these learnings to clinical care.
Stefan Tordenmalm, Market Manager of Processed Food at PerkinElmer, highlights the most common types of food fraud reported by customers and how analytical chemistry helps to ensure food safety and quality.
Iswariya Venkataraman, Scientific Affairs Lead at EUROIMMUN, helped us demystify the differences between the S and N proteins, whose presence indicates the immune response against COVID-19.
Though person-to-person transmission is the primary way of spreading COVID-19, environmental surfaces should also not be neglected. PerkinElmer’s environmental testing kits help detect the virus on surfaces such as plastic, ceramic, or stainless steel.
With COVID-19 continuing to spread and flu season on the way, methanol recalls in hand sanitizers are unwelcomed news. Helping to ensure the safety of these high-demand products, PerkinElmer launched the enhanced Hand Sanitizer Analyzer providing methanol pass/fail results in 30 seconds starting at 300 ppm.
PerkinElmer CEO Prahlad Singh joined Jim Cramer on CNBC’s Mad Money to discuss the how the company’s unique, comprehensive turnkey solutions help in the fight against COVID-19.
The new series of explorer™ workstations for COVID-19 testing can prepare and run up to 10,000 COVID-19 tests daily. These modular and scalable workstations will increase testing capacity for quicker results.
Sonoma County aims to triple volume of coronavirus test processing with new technologyRachel Rees, director of the public health lab in Sonoma County, California, envisions the lab conducting 900 to 1,200 virus tests per day with PerkinElmer’s technology.
Arvind Kothandaraman, General Manager of Specialty Diagnostics at PerkinElmer, shares seven key factors that organizations should take into consideration when choosing a new COVID-19 testing workflow.
PerkinElmer is dedicated to providing labs with LC-MS software interface and analytical management platforms that are easy to use. Prof. Antonio D’Avolio at the University of Turin talks about how this technology is used to quantify remdesivir, the potential cure for COVID-19.
As global scientists work tirelessly to discover therapeutics and vaccines for COVID-19, there’s massive amounts of existing data that can be invaluable. PerkinElmer has introduced open COVID-19 Data Dashboards to help scientists easily access, analyze and gain insights from data sources.
Equipped with a modern user interface and simplified data connectivity, PerkinElmer’s Perten Glutomatic® 2000 System is designed to operate within automated process workflows.
In the part two of the Analytical Cannabis series, Toby Astill from PerkinElmer shared thoughts on topics like adulterant, stability and potency in regard to analyzing cannabis-infused products.
HCS is a powerful tool to help fight viral foes like COVID-19, Ebola, MERS and Zika. Dr. Karin Bottcher talks about how high content screening (HCS) has been used globally to help with drug discovery for repurposing existing drug candidates and creating new therapeutics and vaccines.
Compared with 2D cultures, more complex cultures that use primary cells and multiple cell types in three dimensions provide more physiologically-relevant data for use in target validation.
“FemTech” is a technology that addresses a variety of women’s health issues and according to Karen Madden, Ph.D., Vice President of Technology and Innovation at PerkinElmer, it is gaining more attention. She also shared insights into the Company's Vanadis non-invasive prenatal testing (NIPT) solutions.
Karen Madden, Ph.D., Vice President of Technology and Innovation at PerkinElmer, spoke with The Boston Globe to talk about the current trend and outlook of precision medicine.
With viral tests manufactured by PerkinElmer, Sema4, a Stamford-headquartered firm, has expanded its capacity to run about 15,000 COVID-19 tests per day.
In the first half of the Analytical Cannabis series, our expert Toby Astill discussed the product development and manufacturing of cannabis-based beverages.
PerkinElmer partners with Public Health Wales (PHW) to achieve the Welsh Government’s “Test, Trace, Protect” strategy by providing advanced extraction equipment and testing kits that meet the UK’s ongoing requirements.
With the new EURORealTime SARS-CoV-2 assay, PerkinElmer expands its COVID-19 comprehensive testing portfolio to three FDA EUA solutions.
PerkinElmer has announced the addition of the DELFIA Xpress sFlt-1 kit to its CE-IVD pre-eclampsia product offering to aid in diagnosis in the second and third trimesters of pregnancy.
eXXpedition the all-female microplastics research vessel has returned to dry land due to COVID-19 but continues gaining scientific insights using our FT-IR technology.
PerkinElmer LactoScope FT-B instrument offers rapid and accurate component testing and adulterant screening for dairy products. This instrument can be paired with other PerkinElmer platforms to achieve exhaustive performance.
Amidst COVID-19, PerkinElmer is ready to support our global customers with a wide range of solutions, including detection, workflow and research.
EUROIMMUN Anti-SARS-CoV-2 ELISA testing kits are helping Beaumont Health as part of its research study demystify COVID-19 as the research expands to wider patient groups.
EUROIMMUN provides LabCorp with dried blood spot antibody tests to screen employers as their return-to-work plans.
PerkinElmer Solus One Salmonella, an assay that offers solutions to analyze select foods and delivers results within one day, obtained OMA from AOAC INTERNATIONAL, which is considered the highest level of AOAC certification.
After CE marked in Europe, PerkinElmer’s Anti-SARS-CoV-2 ELISA serological test receives Emergency Use Authorization (EUA) from the FDA.
PerkinElmer’s MaxSignalTM HTS Nitrofurans and Chloramphenicol ELISA Kits offer same-day testing for all five targeted antibiotic residues in farmed shrimp with high accuracy.
Stefan Tordenmalm, Market Manager of Processed Food at PerkinElmer, shares his thoughts about the adulteration of olive oil, which is at high risk for food fraud. To ensure its quality, rapid testing techniques like infrared (IR) and UV-visible spectroscopy (UV-Vis) are crucial in protecting consumers./p>
PerkinElmer’s record for positive social and environmental impact is recognized in story on company’s efforts to expand COVID-19 testing in Texas.
Tailored for pharmaceutical, semiconductor, biomonitoring, food, materials and academia labs, PerkinElmer’s new analysis and automation solutions are designed to help streamline workflows, sharpen insights and meet regulations.
To answer the need for wider COVID-19 testing in the US, EUROIMMUN, a PerkinElmer company, collaborates with Quest Diagnostics to detect immunoglobulin class G (IgG) antibodies. Quest is expected to boost testing to 150,000 a day by early May.
PerkinElmer EUROLabWorkstations and EUROIMMUN Anti-SARS-CoV-2 ELISA testing kits designed to help Beaumont Health gain knowledge about disease transmission and whether COVID-19 antibodies offer protection after infection.
PerkinElmer’s instruments contribute to an antibody study at Beaumont Health, which could potentially identify those with immunity against COVID-19.
Alan Fletcher, vice president and GM, life sciences, shares insights about leveraging the potential of existing drugs to combat COVID-19.
As part of the donation from researchers at Augusta University and Georgia Tech, PerkinElmer’s products help with COVID-19 testing at the GEM lab of Medical College of Georgia.
PerkinElmer’s RT-PCR test assists in screening for COVID-19 at the Clinical and Translational Research Center, University at Buffalo. This effort helps combat COVID-19 in Erie County, NY.
PerkinElmer’s automated lab solutions support Rutgers' RUCDR Infinite Biologics, handling 10,000 nucleic acid extractions per day.
To support the diagnostics of COVID-19, the Anti-SARS-CoV-2 ELISAs for immunoglobulin classes A and G from EUROIMMUN, a PerkinElmer company, is now CE marked in Europe.
PerkinElmer receives Emergency Use Authorization (EUA) from the FDA for the PT-PCR test for detection of COVID-19.
Dr. Stan Naides, the Director of Scientific Affairs at EUROIMMUN, a PerkinElmer company, shares his perspective on COVID-19, its progression and impact on laboratories and their personnel.
In this interview, Petra Furu, the General Manager of Reproductive Health at PerkinElmer, talks about the recently approved DMD screening kit and the promise of non-invasive testings.
Statistics show that women in China are more likely to be in senior leadership roles than many other Asian countries. Here Ms. Ye (Nicky) Xu, General Manager of Diagnostics at PerkinElmer Greater China shares her journey and some career, business and personal growth tips to help inspire the world’s women in science and healthcare.
PerkinElmer’s VICTOR EnLite Instrument and EnLite Neonatal TREC Kit will be available as part of a Severe Combined Immunodeficiency (SCID) evaluation program in collaboration with Public Health England.
When added with LPC 500™ Liquid Particle Counter, PerkinElmer’s Avio® 500 ICP-OES can analyze oils or lubricants for both wear metals and particles in one run. This costs less than 1 mL of sample and takes 45 seconds to provide accurate and stable results.
PerkinElmer launches top technologies at the Society for Laboratory Automation and Screening (SLAS) in San Diego. Highlighted products include JANUS® G3 Blood iQ™ Workstation, Sciclone® G3 NGSx HT Workstation as well as Opera Phenix® Plus High Content Screening System.
To ensure the safety of medicines, PerkinElmer offers pharma companies a comprehensive solution to detect N-nitrosodimethylamine (NDMA) impurity in ranitidine.
PerkinElmer’s liquid handling workstations facilitate sample tracking by incorporating automated barcode scanning into every step of sample processing.
Lead scientist of the eXXpedition research boat Dr. Winnie Courtene-Jones shares how the portable and powerful Spectrum Two FT/IR Spectrometer is being used on board to test for microplastics in our oceans.
As an AI-driven technology solution provider, PerkinElmer is enhancing researchers’ ability to analyze massive amounts of data in a timely fashion.
Together with PerkinElmer, New York State has screened the first infant for Duchenne as part Parent Project Muscular Dystrophy’s (PPMD's) Newborn Screening Pilot.
Cannabis and hemp labs need high quality, end-to-end testing and analysis solutions to keep up with growing demand and regulations. PerkinElmer is teaming up with Emerald Scientific to help.
With PerkinElmer’s spectrometer on board, the all-women research voyage is on the mission of identifying and documenting microplastics during the sails.
Duchenne Muscular Dystrophy is a rare genetic disorder and the most prevalent type of muscular dystrophy. The FDA has approved PerkinElmer’s GSP® Neonatal Creatine Kinase-MM (CK-MM) kit for DMD screening.
ESPGHAN recently updated guidelines for the diagnosis of Celiac disease, which are expected to be more widespread and easy for both patients and gastroenterologists.
Have you ever thought AI can help diagnose genetic disorders? A Boston company is helping clinicians narrow down a patient’s diagnosis out of thousands of disorders with facial recognition technology.
AI and machine learning can help pharmas repurpose failed clinical trial data to drive new breakthroughs and treatments. David Wang, Masha Hoffey and Dr. Simone Sharma discuss key considerations and best practices.
PerkinElmer's new MuviCyte live-cell imaging system helps researcher study cell behavior and function in new ways. Karin Boettcher weighs in on the importance of controlling environmental parameters with advanced innovation.
PerkinElmer offers high-throughput platforms for electrophoresis-based biomolecule separation, sizing, and quantitation.
Mycotoxin testing for grains is a key step in securing global food safety. PerkinElmer’s Mark McBeath discusses best practices and innovative solutions for analysis from strips to LC-MS/MS.
PerkinElmer Genomics will begin processing about 2,500 samples with the Vanadis non-invasive prenatal testing (NIPT) system in Pittsburgh and Kuala Lumpur.
In this article PerkinElmer’s Toby Astill and Aaron Hineman weigh in on the use of ICP-MS to tackle heavy metals testing in cannabis.
Rice is a mega-staple for global consumers and testing for rice quality is key. The newPaddyCheck testing platform speeds sample throughput, increases accuracy and allows for grain testing at the paddy stage whether in-field or in a lab.
PerkinElmer launched the PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing Kit, which tests spent embryo culture media for chromosomal abnormalities during in vitro treatment.
PerkinElmer is exploring the use of deep learning methods to improve analysis of image data from high content screening—in some cases, solving problems that conventional algorithms can’t.
Food safety is paramount. In this byline, PerkinElmer’s Greg Sears discusses advances in testing and analysis for everything from heavy metals, pesticides and mycotoxins, to foodborne pathogens and antibiotics.
A new clinical study further validates PerkinElmer’s Vanadis non-invasive prenatal testing (NIPT) system, which uses fully-automated imaging instead of DNA sequencing or PCR amplification.
Dr. Madhuri Hegde of PerkinElmer Genomics talks about the critical role that genetic counseling plays in consumer-initiated DNA testing today.
In this video, Justin Waldron of EUROIMMUN provides an overview of the high-capacity EUROLabWorkstation at AACC 2019.
To battle food fraud, PerkinElmer’s Greg Sears and Stefan Tordenmalm explain how robust analytical and informatics solutions can detect and analyze adulterants throughout the supply chain.
Beachcombing in Spain drew PerkinElmer’s Ian Robertson into not only his main field of research but an endeavor that fuels debate on microplastics in bottled water.
Linh Hoang, PerkinElmer’s vice president of Reproductive Health, spoke with Bloomberg about molecular testing options available right now for screening newborns with SMA (spinal muscular atrophy).
Angelo Filosa of PerkinElmer OneSource explains how working with a relocation service provider can minimize disruptions to daily operations and ensure a successful lab move.
In this article, Dr. Marc Pollmann, EUROIMMUN biologist, outlines the factors that play into accurate identification, diagnosis and treatment of tickborne illnesses like Lyme disease.
PerkinElmer and FDNA have partnered to offer genomic services paired with next-generation phenotyping technologies. The new service combines PerkinElmer Genomics' Ordered Data Interpretation Network (ODIN) software platform with FDNA's Face2Gene facial analysis technology.
Today more than half of all US citizens -- and people from 44 other countries -- have access to legal medical cannabis. As this market continues to grow and becomes more mainstream, calls for regulation and the need for the cannabis industry to ensure patient and consumer safety will similarly increase.
Prahlad Singh, president and chief operating officer, shares an update on PerkinElmer's new office facility in Singapore and growing customer base throughout Southeast Asia.
PerkinElmer is supporting the launch of Parent Project Muscular Dystrophy's (PPMD) pilot program to screen newborns in New York state for Duchenne—one of the most common forms of muscular dystrophy.
Researchers are looking for ways to more easily and effectively access, analyze and spotlight scientific data that is growing in volume and complexity and often dispersed across hard-to-access silos.
PerkinElmer will integrate its big data technology and content into Accenture's cloud-based platform, designed to drive wider efforts in drug discovery and research.
PerkinElmer was recognized as a leader in the scientific instrument industry at the 13th China Scientific Instrument Annual Conference.
As part of our mission to innovate for a healthier world, PerkinElmer is providing laboratories with the analytical tools needed to ensure safe, high-quality and compliant cannabis products.
PerkinElmer will relocate its Canadian demonstration lab to Velocity Garage, giving entrepreneurs and scientists access to the company's lab instruments, software and experts.
As with many sectors of the food market, the dairy and dairy product industry is evolving. A growing world population, rising standards of living in developing nations and increases in product variety are reshaping the industry.
Emerald Scientific awarded the "Emerald Test" badges to PerkinElmer, affirming our instruments' ability to accurately detect pesticides, heavy metals, residual solvents, terpenes and potency in cannabis.
Optimization of experimental assay design is crucial for the overall success of any drug discovery initiative.
Dr. Linh Hoang, M.D., Ph.D., vice president of Reproductive Health, outlines why early detection of preeclamspia provides a valuable window of opportunity for vigilance and intervention.
In this "Bold Types" feature, CFO Jamey Mock highlights some of the ways PerkinElmer will look to drive future growth.
Drug development is facing change from both technological pressures, including the use of AI and machine learning, and new regulations, which are transforming the way electronic records are created and stored for clinical trials.
For cannabis and hemp analysis, the high sensitivity of the QSight 400 Series supports laboratories in meeting state and federal regulations, including California and Canada.
Monitoring of residues in food substances is critical to ensuring no products are sold that contain dangerous levels of pesticides. Testing for even the smallest amounts of contaminants requires innovative lab equipment to guarantee products meet strict regulatory requirements.
The test, designed for noninvasive prenatal screening for trisomies 21, 18, and 13, with Y chromosome testing as an optional marker, has been validated in an external clinical study in France.
David Wang, general manager of Informatics, explains how scientists can harness valuable information quickly to achieve better, faster outcomes—and expedite the drug discovery process—by taking "the 3Vs" into account.
AI comes in many forms, but machine learning and natural language processing are two which are helping drug discovery scientists find new drug candidates.
EUROIMMUN's Dr. Konstanze Stiba discusses the challenges associated with developing a diagnostic for "Disease X," which represents newly emerging pathogens that present a significant public health risk - with the potential for an international epidemic.
Sanofi Genzyme and PerkinElmer Genomics have launched a free genetic testing program that aims to spot certain undiagnosed lysosomal storage disorders, while raising awareness of the group of rare diseases whose symptoms may initially be ascribed to more common ailments.
Jamey Mock talks about the first 120 days in his role as PerkinElmer CFO.
PerkinElmer scientists are testing cannabis for pesticide and mycotoxin levels using an LC-MS/MS method.
Whole genome and whole exome sequencing will be offered through its laboratories in the U.S., India, and China.
The Avio is designed for analytical labs running high throughput multi-elemental inorganic analyses for a variety of sample matrices.
PerkinElmer’s DELFIA Xpress PIGF 1-2-3 assay has been successfully utilized for identifying and monitoring women who are at risk of preeclampsia as part of Fetal Medicine Foundation’s ASPRE study.
China is making progress in its fight against pollution, though it still has a long way to go.
The deal will expand PerkinElmer's reach into autoimmune and allergy diagnostic markets.
PerkinElmer’s TR-FRET-based homogeneous assays use metal chelates as donor fluorophore.
PerkinElmer's Torion T-9 portable GC/MS brings new meaning to portability.
A new immunoassay developed by PerkinElmer has been demonstrated to successfully screen for Duchenne muscular dystrophy (DMD) – a fatal X-chromosome recessive disorder, affecting 1 in 5000 male births world-wide.
ViaCord helped fund a small, but promising study that suggests stem cells from a child’s own cord blood may offer an effective treatment for autism symptoms.
The endothelial cells that line our blood vessels play an important role in maintaining and regulating blood flow, contributing to the natural process called haemostasis. PerkinElmer Opera Phenix™ system highlighted.
Like many chemists of a certain age, Derek Lowe remembers the exact moment when he learned about the chemical-structure-drawing program we now call ChemDraw.
Technologies such as PerkinElmer’s Opal platform and its multispectral imaging and analysis software allow researchers to multiplex immunology markers in a single assay on a single slide.
In a research first, Tufts scientists have witnessed atoms of one chemical element morph into another.
PerkinElmer, a maker of high-tech equipment used in the pharmaceutical industry, is joining Albany Molecular Research Inc. in a new, multimillion-dollar drug development hub soon to open on the Buffalo Niagara Medical Campus.
To minimize complexity, researchers often study cellular proteins or nucleic acids in isolation.
PerkinElmer of Shelton has received an Aquarion Environmental Champion Award. PerkinElmer company was recognized for its environmental efforts as well as for encouraging employees to participate voluntarily internal and external environmental projects.
PerkinElmer #940 on Fortune 1000.
Pharmaceutical and biotechnology companies are facing a gigantic increase in data — not just in volume, but in complexity.
Kinase assays that are compatible with high-throughput screening techniques are essential.
The goal of scientists is to partake in a breakthrough discovery leading to a solution that makes the world a better place.
For over 60 years, PerkinElmer has been providing unmatched versatility and sensitivity in radiometric detection. The new liquid scintillation counters are the most versatile, sensitive, and comprehensive LSCs on the market.
A report by the E.U. Committee on the Environment, Public Health and Food Safety identifies olive oil as being among the products most prone to food fraud.
Instrument firm executives at the Pittsburgh Conference on Analytical Chemistry & Applied Spectroscopy (Pittcon) this week said they want to see last year’s healthy sales pace continue into 2015.
PerkinElmer (Massachussetts, USA) has announced that they will collaborate with Waters Corporation (Massachussetts, USA) to standardize PerkinElmer liquid chromatography (LC) and gas chromatography (GC) instrumention.
Lab solutions provider PerkinElmer Inc. announced its collaboration with Johnson & Johnson Innovation to equip its JLABS @South San Francisco (JLABS @SSF) life science incubator with instruments and lab services to address the research needs of resident startups.
PerkinElmer Inc., a global leader focused on improving the health and safety of people and the environment, has announced the launch of its Adulterant Screen software.
Lab automation systems are used in R&D laboratories for a wide range of operational applications and purposes.
Operating in over 150 countries, PerkinElmer is one of the global companies listed on the S&P 500 and the Russell 3000 Indices.
An interview with Morey Kraus, Chief Scientific Officer of the Diagnostics division of PerkinElmer, and Kypros Nicolaides, Professor of Fetal Medicine, King's College, London, UK.
Scientific instruments maker PerkinElmer Inc on Thursday reported better-than-expected fourth quarter revenue and profit, helped by strong demand for its newborn screening tests in developing markets.
This new facility provides a comprehensive offering of lab services to hospitals and patients in China, supporting the prevention of birth defects in newborns and infectious disease in adults.
Food fraud is defined by the United Kingdom’s Food Standard Agency as date tampering or selling goods past their use-by date, packing and selling products with an unknown origin, deliberately mislabeling food like farmed salmon as being wild, or using stolen or poached animal meat.
Severe Combined Immunodeficiency (SCID) is a group of disorders caused by defects in genes involved in the development and function of T-cells and other infection-fighting immune cells.
During biosimilar development, it is necessary to demonstrate that the physicochemical properties, efficacy, and safety (e.g., immunogenicity) of the biosimilar are similar to those of the targeted branded biologic.
Robert Roe investigates cloud and SaaS deployment models and the inherent flexibility and scalability they provide to users.
US-based PerkinElmer, Inc. (NYSE: PKI) has completed its acquisition of Sweden-based analytical instruments supplier Perten Instruments Group AB. The deal is worth around USD 266m. Perten supplies instruments for quality control of food, grain, flour and feed.
OncoSec Medical Inc, San Diego, a company developing DNA-based intratumoral cancer immunotherapies, recently announced a collaboration with PerkinElmer Inc and the University of California, Los Angeles (UCLA), to help researchers develop biomarker tests for evaluating a patient’s immune response to cancer.
PerkinElmer has acquired Perten Instruments for $266m to ‘significantly expand’ its presence in the food testing.
PerkinElmer Inc. (PKI) on Thursday reported third-quarter profit of $42.3 million. The results met Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was also for earnings of 57 cents per share.
Perkin Elmer has unveiled its Solaris quantitative optical molecular imaging system for use in small and large animal studies. The Solaris system can bridge molecular imaging research techniques to support potential clinical outcomes.
After a generation of outsourcing services to lower-cost providers, smart companies now realize that they need to reassess this strategy. Outsourcing did lower costs in a time of need, but it came at a high price.
Technology and humans have a two-way action/reaction relationship. Given the concerns over the quality of the air we breathe, one company has developed a small device that can measure local conditions.
PerkinElmer announced an agreement with Sofie Biosciences to commercialize the latter's preclinical PET, 3D CT, and X-ray systems. The partnership will be focusing on areas of research in pharmacology, oncology, immunology, cardiology and neurobiology.
Advocates for the Preeclampsia Foundation, a non-profit organization dedicated to reducing illness and death due to preeclampsia, will be participating in and raising money for the Foundation’s annual The Promise Walk for Preeclampsia™.
26 projects were presented in the science fair, and early this week a panel of judges - from teachers to engineers - came to SIS to look at the students' work.
PerkinElmer Inc. announces the launch of the NexION® 350 Inductively Coupled Plasma Mass Spectrometer (ICP-MS), its atomic spectroscopy product and Syngistix™ for ICP-MS Software, its next generation atomic spectroscopy software platform.
Scientific instruments maker PerkinElmer Inc. reported a higher-than-expected quarterly profit on Thursday, helped by increased demand for its medical diagnostics products and continued double-digit growth in China.
The unique properties of engineered nanoparticles (ENPs) have created intense interest in their environmental behavior. It’s crucial to understand their impact on the growing mechanism of crops used for human consumption.
The Lamina scanner is a high throughput imaging system designed to help research pathologists to more easily study protein expression and the relationships between disease markers in formalin-fixed, paraffin-embedded (FFPE) tissue sections.
Dr. Victor Weeden, GWU Forensics Department are among the first to use mass spectrometry, a highly sensitive technology, that accurately detects trace levels of illicit substances, staying one step ahead of drug makers and criminals.
There is no other food quite like olive oil. There is also, apparently, no better motivator throughout history than the chance to make a quick buck.
PerkinElmer announced that it will release a cloud-based informatics platform that will focus on operational efficiency for collaborative R&D activities.
Good Start Genetics®, Inc. announced a strategic agreement with PerkinElmer, Inc. to expand access to GoodStart Select™ genetic carrier screening tests beyond the in vitro fertilization (IVF) setting to the broader women's health community.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced the launch of the Lamina multilabel slide scanner at the USCAP 2014 Annual Meeting.
A wireless cassette-sized flat panel detector component has been developed for digital radiography (DR) applications. The detector makes a streamlined transition from film to digital, and provides a lower radiation dose.
Danielle, 37, and her husband Akber, 38, from Pakistan, are using their experience to help thousands of other children avoid their little girl’s fate.
Cord blood banking involves collecting and preserving cord stem cells, which are extracted from the umbilical cord and placenta. They can also be extracted and preserved for potential future medical use.
Based on nearly two decades of clinical medicine, there’s no denying the incredible value of cord blood stem cells in treating nearly 80 life threatening diseases of the blood.
Due to economically motivated adulteration (EMA) and mislabeling, it is difficult to predict the exact nature of potential threats, so many in the food industry are looking to detection techniques that help detect “unknown-unknowns.”
Scientific instruments maker PerkinElmer Inc on Thursday forecast full-year earnings in line with current Wall Street estimates and its CEO sees a rosier 2014 after a year filled with uncertainty in the markets it serves.
One of the key characteristics of whisky enjoyment is the aroma from the spirit with a recently designed copita (a tulip-shaped sherry glass), having been developed to maximize this experience.
Label-free technology has been demonstrated to be a robust, highly sensitive, automatable tool used to measure live, native cells in real time.
Whether you employ analytical instrumentation for quality or food safety or both, the type of analytical instrumentation and testing will vary based on where it’s employed in the food process.
PerkinElmer has introduced the AxION iQT GC-MS-MS system which has the identification capabilities of a triple quadruple in one instrument, according to the company.
Whole-animal imaging enables researchers to noninvasively identify a disease and its location within an animal subject, and to monitor disease development over time.
Five employees and one customer of PerkinElmer France teamed up to participate in a 24 h relay bicycle race near Tours (France) in support of cancer research.
Dairy processors are taking a hardline to try to eradicate" adulterants, such as urea and melamine, from milk powder, PerkinElmer has claimed following the launch of its new DairyGuard milk powder analyzer.
The PerkinElmer Informatics 2013 User Group Meeting kicked off at 9:30am EST in Waltham, Mass., with the launch of PKI Informatics' newest electronic laboratory notebook version, E-Notebook 2014.
In 1970, the United States government established the Environmental Protection Agency (EPA) in response to growing public demand for a cleaner environment.
The scientific and regulatory communities have long been aware of the potential for migration of vapors from contaminated subsurface areas into buildings.
PerkinElmer is expanding its Center for Personalized Health Innovation in Hopkinton by more than 50 percent and upping the headcount there, saying it hopes to foster more collaboration with area biotech, pharmaceutical and academic institutions.
Economic adulteration and counterfeiting of global food and consumer products are estimated to cost the industry $10 to $15 billion per year, according to a 2010 A.T. Kearney study.
In 1905, the U.S. Pharmacopeial Convention, the nonprofit standards-setting organization known as USP, introduced a method to check for heavy metals in U.S. pharmaceuticals.
A number of scandals has left consumers nervous about the quality of what they eat and spurred Beijing to take the matter much more seriously.